Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels^®: Toxicity and Efficacy Analysis on a Retrospective Series of 305 Patients

References

• Bruni A, Ingrosso G, Trippa F, et al. Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy? Clin Transl Oncol. 2019;21(11):1532–1537. doi:10.1007/s12094-019-02084-0
   PubMed Web of Science ®Google Scholar
• Arcangeli S, Ramella S, De bari B, Franco P, Alongi F, D’Angelillo RM. A cast of shadow on adjuvant radiotherapy for prostate cancer: a critical review based on a methodological perspective. Crit Rev Oncol Hematol. 2016;97:322–327. doi:10.1016/j.critrevonc.2015.09.005
   PubMed Web of Science ®Google Scholar
• Kneebone A, Fraser-Browne C, Duchesne GM, et al. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, Phase 3, non-inferiority trial. Lancet Oncol. 2020;21(10):1331–1340. doi:10.1016/S1470-2045(20)30456-3
   PubMed Web of Science ®Google Scholar
• Sargos P, Chabaud S, Latorzeff I, et al. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial. Lancet Oncol. 2020;21(10):1341–1352. doi:10.1016/S1470-2045(20)30454-X
   PubMed Web of Science ®Google Scholar
• Parker CC, Clarke NW, Cook AD, et al. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. Lancet. 2020;396(10260):1413–1421. doi:10.1016/S0140-6736(20)31553-1
   PubMed Web of Science ®Google Scholar
• Vale CL, Fisher D, Kneebone A, et al. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. Lancet. 2020;396(10260):1422–1431. doi:10.1016/S0140-6736(20)31952-8
   PubMed Web of Science ®Google Scholar
• Robin S, Jolicoeur M, Palumbo S, et al. Prostate bed delineation guidelines for postoperative radiation therapy: on behalf of the Francophone Group of Urological Radiation Therapy. Int J Radiat Oncol Biol Phys. 2020;109:1243–1253. doi:10.1016/j.ijrobp.2020.11.010
   PubMedGoogle Scholar
• Alongi F, Cozzi L, Fogliata A, et al. Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancer. Anticancer Res. 2013;33(10):4537–4543.
   PubMed Web of Science ®Google Scholar
• Dasu A, Toma-Dasu I. Prostate alpha/beta revisited – an analysis of clinical results from 14 168 patients. Acta Oncol. 2012;51(8):963–974. doi:10.3109/0284186X.2012.719635
   PubMed Web of Science ®Google Scholar
• Picardi C, Perret I, Miralbell R, Zilli T. Hypofractionated radiotherapy for prostate cancer in the postoperative setting: what is the evidence so far? Cancer Treat Rev. 2018;62:91–96. doi:10.1016/j.ctrv.2017.11.004
   PubMed Web of Science ®Google Scholar
• Chin S, Fatimilehin A, Walshaw R, et al. Ten-year outcomes of moderately hypofractionated salvage postprostatectomy radiation therapy and external validation of a contemporary multivariable nomogram for biochemical failure. Int J Radiat Oncol Biol Phys. 2020;107(2):288–296. doi:10.1016/j.ijrobp.2020.01.008
   PubMed Web of Science ®Google Scholar
• Cozzarini C, Fiorino C, Deantoni C, et al. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients. Eur Urol. 2014;66(6):1024–1030. doi:10.1016/j.eururo.2014.06.012
   PubMed Web of Science ®Google Scholar
• Fersino S, Fiorentino A, Giaj Levra N, et al. Impact of Ialuril Soft Gels in reducing urinary toxicity during radical hypofractionated radiotherapy in prostate cancer: a preliminary experience. Minerva Urol Nefrol. 2016;68(1):9–13.
   PubMed Web of Science ®Google Scholar
• Gacci M, Saleh O, Giannessi C, et al. Bladder instillation therapy with hyaluronic acid and chondroitin sulfate improves symptoms of postradiation cystitis: prospective pilot study. Clin Genitourin Cancer. 2016;14(5):444–449. doi:10.1016/j.clgc.2016.01.016
   PubMed Web of Science ®Google Scholar
• Poortmans P, Bossi A, Vandeputte K, et al. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiother Oncol. 2007;84(2):121–127. doi:10.1016/j.radonc.2007.07.017
   PubMed Web of Science ®Google Scholar
• Francolini G, Timon G, Matrone F, et al. Postoperative radiotherapy after upfront radical prostatectomy: debated issues at a turning point-A survey exploring management trends on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology). Clin Transl Oncol. 2021;23(12):2568–2578. doi:10.1007/s12094-021-02665-y
   PubMed Web of Science ®Google Scholar
• Flores-Balcázar CH, Urías-Arce DM, Bourlon MT, et al. Transitioning from conformal radiotherapy to intensity-modulated radiotherapy after radical prostatectomy: clinical benefit, oncologic outcomes and incidence of gastrointestinal and urinary toxicities. Rep Pract Oncol Radiother. 2020;25(4):568–573. doi:10.1016/j.rpor.2020.04.018
   PubMedGoogle Scholar
• Barra S, Belgioia L, Marcenaro M, et al. Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome. Cancer Manag Res. 2018;10:473–480. doi:10.2147/CMAR.S146131
   PubMed Web of Science ®Google Scholar
• Cuccia F, Mortellaro G, Serretta V, et al. Hypofractionated postoperative helical tomotherapy in prostate cancer: a mono-institutional report of toxicity and clinical outcomes. Cancer Manag Res. 2018;10:5053–5060. doi:10.2147/CMAR.S182016
   PubMed Web of Science ®Google Scholar
• Tandberg DJ, Oyekunle T, Lee WR, Wu Y, Salama JK, Koontz BF. Postoperative radiation therapy for prostate cancer: comparison of conventional versus hypofractionated radiation regimens. Int J Radiat Oncol Biol Phys. 2018;101(2):396–405. doi:10.1016/j.ijrobp.2018.02.002
   PubMed Web of Science ®Google Scholar